Jan 20, 2023
More on Compliance & Legal
Top Stories: California files suit against drugmakers; GH Healthcare to acquire IMPACTIS
The AG's office accused drugmakers of "unlawful, unfair, and deceptive business practices."
Photo: Pichsakul Promrungsee EyeEm/Getty Images
The State of California is suing pharmaceutical manufacturers. Why are they doing it? We'll examine the answers to that and more in this week's Top Stories, including GE Healthcare's agreement to but French company IMPACTIS, and SickKids' recent ransomware scare.
For more news and features from Jeff Lagasse, visit Healthcare Finance News.
In this episode:
- California sues drugmakers and PBMs over insulin
- GE HealthCare announces first acquisition as independent company
- Second major Toronto hospital experiences 'Code Grey'
Talking points:
- The lawsuit alleges that manufacturers Eli Lilly, Novo Nordisk and Sanofi, and pharmacy benefit managers CVS Caremark, Express Scripts and OptumRx, have leveraged their market power to overcharge patients.
- The three manufacturers named in the lawsuit produce more than 90% of the global insulin supply, and the three PBMs administer pharmacy benefits for roughly 80% of prescription claims managed.
- Financial details for the transaction weren't disclosed, but GE HealthCare said it plans to fund the acquisition with cash on hand.
- UHN announced that there had been no breach of patient data, and indicated the outage was due to issues with its network.
Twitter: @JELagasse
Email the writer: Jeff.Lagasse@himssmedia.com
